Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural Products Expo West In Brief

This article was originally published in The Tan Sheet

Executive Summary

Tom's of Maine: Company extends its anticavity line with new Natural Anticavity plus Whitening fluoride toothpastes in both gel and liquid gel formulations. Silica, a mild abrasive derived from sand, provides products with natural whitening power without bleaching or harsh abrasives, Kennebunk, Maine-based firm says. Gel versions, sold in 5.5 oz tubes with an SRP of $4.79, come in five flavors including spearmint, peppermint, cinnamint, orange-mango and wintermint. Liquid gel toothpastes in peppermint, spearmint, cinnamint, and fennel flavors come in two sizes: 4.58 oz. and travel-convenient 1.5 oz carry SRPs of $4.49 and $2.79, respectively. Launch began in January and will continue through March. Both varieties will be available in 50,000 health and mass retail locations by May...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel